Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $385.7600 (0.03%) ($385.7600 - $385.7600) on Fri. Jan. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.53% (three month average) | RSI | 64 | Latest Price | $385.7600(0.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 1.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.765% in a week (0% probabilities). VIXM(-23%) VXX(-10%) TLT(-5%) TIP(-1%) UUP(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.765% (StdDev 1.53%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $385.82(-0.02%) | 10 Day Moving Average | $382.47(0.86%) | 20 Day Moving Average | $378.34(1.96%) | To recent high | -1.3% | To recent low | 29.4% | Market Cap | $40.902b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |